相似文献
1
Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1130-3. doi: 10.1073/pnas.88.4.1130.
2
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Br J Pharmacol. 1991 Sep;104(1):239-45. doi: 10.1111/j.1476-5381.1991.tb12413.x.
3
Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Br J Pharmacol. 1993 Aug;109(4):913-7. doi: 10.1111/j.1476-5381.1993.tb13707.x.
4
Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice.
Neurosci Lett. 1993 Oct 1;160(2):193-6. doi: 10.1016/0304-3940(93)90411-d.
5
Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
Peptides. 1996;17(3):483-8. doi: 10.1016/0196-9781(96)00028-9.
6
Possible role of cholecystokinin-A receptors in regulation of thyrotropin (TSH) secretion in male rats.
Neuropeptides. 1992 Dec;23(4):251-8. doi: 10.1016/0143-4179(92)90132-g.
7
Use of ex vivo binding to estimate brain penetration and central activity of CCK-B antagonists.
Ann N Y Acad Sci. 1994 Mar 23;713:360-3. doi: 10.1111/j.1749-6632.1994.tb44093.x.
8
Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.
J Neurosci. 1997 Mar 1;17(5):1838-47. doi: 10.1523/JNEUROSCI.17-05-01838.1997.
9
'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.
Brain Res. 1991 May 10;548(1-2):315-7. doi: 10.1016/0006-8993(91)91139-r.
10
Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
J Neurosci. 1992 Sep;12(9):3380-91. doi: 10.1523/JNEUROSCI.12-09-03380.1992.
引用本文的文献
1
Neuropeptide-mediated activation of astrocytes improves stress resilience in mice by modulating cortical neural synapses.
Acta Pharmacol Sin. 2025 Apr;46(4):867-879. doi: 10.1038/s41401-024-01420-7. Epub 2024 Dec 6.
2
Is the Use of Glyphosate in Modern Agriculture Resulting in Increased Neuropsychiatric Conditions Through Modulation of the Gut-brain-microbiome Axis?
Front Nutr. 2022 Mar 8;9:827384. doi: 10.3389/fnut.2022.827384. eCollection 2022.
3
Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes.
PLoS One. 2021 Sep 10;16(9):e0256655. doi: 10.1371/journal.pone.0256655. eCollection 2021.
4
Ancient role of sulfakinin/cholecystokinin-type signalling in inhibitory regulation of feeding processes revealed in an echinoderm.
Elife. 2021 Sep 7;10:e65667. doi: 10.7554/eLife.65667.
5
The neural circuitry of social homeostasis: Consequences of acute versus chronic social isolation.
Cell. 2021 Mar 18;184(6):1500-1516. doi: 10.1016/j.cell.2021.02.028. Epub 2021 Mar 9.
6
Region-specific brain area reductions and increased cholecystokinin positive neurons in diabetic OLETF rats: implication for anxiety-like behavior.
J Physiol Sci. 2020 Sep 16;70(1):42. doi: 10.1186/s12576-020-00771-0.
7
Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109761. doi: 10.1016/j.pnpbp.2019.109761. Epub 2019 Sep 14.
8
Cholecystokinin induces crowing in chickens.
Sci Rep. 2019 Mar 8;9(1):3978. doi: 10.1038/s41598-019-40746-9.
9
Non-sulfated cholecystokinin-8 reduces meal size and prolongs the intermeal interval in male Sprague Dawley rats.
Neuropeptides. 2019 Feb;73:57-65. doi: 10.1016/j.npep.2018.11.003. Epub 2018 Nov 13.
10
Validation of candidate anxiety disorder genes using a carbon dioxide challenge task.
Biol Psychol. 2015 Jul;109:61-6. doi: 10.1016/j.biopsycho.2015.04.006. Epub 2015 Apr 22.
本文引用的文献
1
The morphology and distribution of peptide-containing neurons in the adult and developing visual cortex of the rat. III. Cholecystokinin.
J Neurocytol. 1982 Dec;11(6):881-95. doi: 10.1007/BF01148306.
2
Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography.
Regul Pept. 1981 Apr;2(1):15-30. doi: 10.1016/0167-0115(81)90062-8.
3
Distinct cholecystokinin receptors in brain and pancreas.
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6917-21. doi: 10.1073/pnas.77.11.6917.
4
Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour.
Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):1-5. doi: 10.1007/BF00504983.
5
Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material.
J Neurosci. 1984 Oct;4(10):2590-603. doi: 10.1523/JNEUROSCI.04-10-02590.1984.
6
Metrazol tolerance in a "normal" volunteer population. A ten year follow-up report.
J Nerv Ment Dis. 1970 Jun;150(6):438-43. doi: 10.1097/00005053-197006000-00003.
7
Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrins.
Ann N Y Acad Sci. 1985;448:11-23. doi: 10.1111/j.1749-6632.1985.tb29902.x.
8
Species differences in the localization of 'peripheral' type cholecystokinin receptors in rodent brain.
Neurosci Lett. 1987 Aug 31;79(3):286-9. doi: 10.1016/0304-3940(87)90445-9.
9
Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists.
J Neurosci. 1987 Sep;7(9):2967-76. doi: 10.1523/JNEUROSCI.07-09-02967.1987.
10
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4923-6. doi: 10.1073/pnas.83.13.4923.
Zotero 插件